ReviewVascular health and risk management2013

Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.

Richard KonesPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.